Related Articles
Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer
Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management
Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer
Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity